Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37


Transplant Outcomes in Destination Therapy Left Ventricular Assist Device Patients.

Miller RJH, Moayedi Y, Sharma A, Haddad F, Hiesinger W, Banerjee D.

ASAIO J. 2019 Jun 6. doi: 10.1097/MAT.0000000000001016. [Epub ahead of print]


Predicting Transfusions During Left Ventricular Assist Device Implant.

Miller RJH, Gregory AJ, Kent W, Banerjee D, Hiesinger W, Clarke B.

Semin Thorac Cardiovasc Surg. 2019 May 22. pii: S1043-0679(19)30151-0. doi: 10.1053/j.semtcvs.2019.05.015. [Epub ahead of print]


Successful Repair of Type A Aortic Dissection in an Octogenarian With Double Aortic Arch.

Zeigler SM, Hiesinger W.

Ann Thorac Surg. 2019 Jan;107(1):e19-e21. doi: 10.1016/j.athoracsur.2018.05.082. Epub 2018 Jul 2.


The Incremental Value of Right Ventricular Size and Strain in the Risk Assessment of Right Heart Failure Post - Left Ventricular Assist Device Implantation.

Aymami M, Amsallem M, Adams J, Sallam K, Moneghetti K, Wheeler M, Hiesinger W, Teuteberg J, Weisshaar D, Verhoye JP, Woo YJ, Ha R, Haddad F, Banerjee D.

J Card Fail. 2018 Dec;24(12):823-832. doi: 10.1016/j.cardfail.2018.10.012. Epub 2018 Oct 26.


Right ventricular load adaptability metrics in patients undergoing left ventricular assist device implantation.

Amsallem M, Aymami M, Hiesinger W, Zeigler S, Moneghetti K, Marques M, Teuteberg J, Ha R, Banerjee D, Haddad F.

J Thorac Cardiovasc Surg. 2018 Sep 25. pii: S0022-5223(18)32490-5. doi: 10.1016/j.jtcvs.2018.08.095. [Epub ahead of print]


Planned Concomitant Left and Right Ventricular Assist Device Insertion to Avoid Long-term Biventricular Mechanical Support: Bridge to Right Ventricular Recovery.

Salna M, Shudo Y, Teuteberg JJ, Banerjee D, Ha RV, Woo YJ, Hiesinger W.

Heart Surg Forum. 2018 Oct 1;21(5):E412-E414. doi: 10.1532/hsf.2035.


Prolonged veno-arterial extracorporeal life support for cardiac failure.

Guenther SP, Shudo Y, Hiesinger W, Banerjee D.

Int J Artif Organs. 2018 Aug;41(8):437-444. doi: 10.1177/0391398818777359. Epub 2018 Jun 13.


An innovative biologic system for photon-powered myocardium in the ischemic heart.

Cohen JE, Goldstone AB, Paulsen MJ, Shudo Y, Steele AN, Edwards BB, Patel JB, MacArthur JW Jr, Hopkins MS, Burnett CE, Jaatinen KJ, Thakore AD, Farry JM, Truong VN, Bourdillon AT, Stapleton LM, Eskandari A, Fairman AS, Hiesinger W, Esipova TV, Patrick WL, Ji K, Shizuru JA, Woo YJ.

Sci Adv. 2017 Jun 14;3(6):e1603078. doi: 10.1126/sciadv.1603078. eCollection 2017 Jun.


Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.

MacArthur JW, Steele AN, Goldstone AB, Cohen JE, Hiesinger W, Woo YJ.

Curr Treat Options Cardiovasc Med. 2017 Apr;19(4):30. doi: 10.1007/s11936-017-0530-x. Review.


Operative technique and pitfalls in donor heart procurement.

Shudo Y, Hiesinger W, Oyer PE, Woo YJ.

Asian Cardiovasc Thorac Ann. 2017 Jan;25(1):80-82. doi: 10.1177/0218492316678716. Epub 2016 Nov 12.


Cell transplantation in heart failure: where do we stand in 2016?

MacArthur JW, Goldstone AB, Cohen JE, Hiesinger W, Woo YJ.

Eur J Cardiothorac Surg. 2016 Sep;50(3):396-9. doi: 10.1093/ejcts/ezw230. No abstract available.


Hybrid coronary revascularization: Ready for prime time, but who should star?

Hiesinger W, Atluri P.

J Thorac Cardiovasc Surg. 2016 Apr;151(4):1090-1. doi: 10.1016/j.jtcvs.2015.12.015. Epub 2015 Dec 13. No abstract available.


Building a better bridge: Remodeling, recovery, and a better understanding of the biologic foundation of mechanical circulatory support.

Hiesinger W, Atluri P.

J Thorac Cardiovasc Surg. 2015 Nov;150(5):1342-3. doi: 10.1016/j.jtcvs.2015.09.042. Epub 2015 Sep 18. No abstract available.


Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb.

Edwards BB, Fairman AS, Cohen JE, MacArthur JW Jr, Goldstone AB, Woo JB, Hiesinger W, Woo YJ.

J Vasc Surg. 2016 Oct;64(4):1093-9. doi: 10.1016/j.jvs.2015.06.140. Epub 2015 Sep 12.


A Tissue-Engineered Chondrocyte Cell Sheet Induces Extracellular Matrix Modification to Enhance Ventricular Biomechanics and Attenuate Myocardial Stiffness in Ischemic Cardiomyopathy.

Shudo Y, Cohen JE, MacArthur JW, Goldstone AB, Otsuru S, Trubelja A, Patel J, Edwards BB, Hung G, Fairman AS, Brusalis C, Hiesinger W, Atluri P, Hiraoka A, Miyagawa S, Sawa Y, Woo YJ.

Tissue Eng Part A. 2015 Oct;21(19-20):2515-25. doi: 10.1089/ten.TEA.2014.0155. Epub 2015 Sep 18.


A "Repair-All" Strategy for Degenerative Mitral Valve Disease Safely Minimizes Unnecessary Replacement.

Goldstone AB, Cohen JE, Howard JL, Edwards BB, Acker AL, Hiesinger W, MacArthur JW Jr, Atluri P, Woo YJ.

Ann Thorac Surg. 2015 Jun;99(6):1983-90; discussion 1990-1. doi: 10.1016/j.athoracsur.2014.12.076. Epub 2015 Apr 9.


Ventricular assist device implantation in the elderly.

Hiesinger W, Boyd JH, Woo YJ.

Ann Cardiothorac Surg. 2014 Nov;3(6):570-2. doi: 10.3978/j.issn.2225-319X.2014.09.07.


A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.

Cohen JE, Purcell BP, MacArthur JW Jr, Mu A, Shudo Y, Patel JB, Brusalis CM, Trubelja A, Fairman AS, Edwards BB, Davis MS, Hung G, Hiesinger W, Atluri P, Margulies KB, Burdick JA, Woo YJ.

Circ Heart Fail. 2014 Jul;7(4):619-26. doi: 10.1161/CIRCHEARTFAILURE.113.001273. Epub 2014 Jun 5.


Bioengineered stromal cell-derived factor-1α analogue delivered as an angiogenic therapy significantly restores viscoelastic material properties of infarcted cardiac muscle.

Trubelja A, MacArthur JW, Sarver JJ, Cohen JE, Hung G, Shudo Y, Fairman AS, Patel J, Edwards BB, Damrauer SM, Hiesinger W, Atluri P, Woo YJ.

J Biomech Eng. 2014 Aug;136(8). doi: 10.1115/1.4027731.


Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model.

Macarthur JW Jr, Cohen JE, McGarvey JR, Shudo Y, Patel JB, Trubelja A, Fairman AS, Edwards BB, Hung G, Hiesinger W, Goldstone AB, Atluri P, Wilensky RL, Pilla JJ, Gorman JH 3rd, Gorman RC, Woo YJ.

Circ Res. 2014 Feb 14;114(4):650-9. doi: 10.1161/CIRCRESAHA.114.302884. Epub 2013 Dec 23.


Therapeutic potential of Rb phosphorylation in atherosclerosis.

Hiesinger W, Cohen JE, Atluri P.

Cell Cycle. 2014;13(3):352. doi: 10.4161/cc.27551. Epub 2013 Dec 17. No abstract available.


Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.

MacArthur JW Jr, Purcell BP, Shudo Y, Cohen JE, Fairman A, Trubelja A, Patel J, Hsiao P, Yang E, Lloyd K, Hiesinger W, Atluri P, Burdick JA, Woo YJ.

Circulation. 2013 Sep 10;128(11 Suppl 1):S79-86. doi: 10.1161/CIRCULATIONAHA.112.000343.


Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era.

Atluri P, Goldstone AB, Fairman AS, MacArthur JW, Shudo Y, Cohen JE, Acker AL, Hiesinger W, Howard JL, Acker MA, Woo YJ.

Ann Thorac Surg. 2013 Sep;96(3):857-63; discussion 863-4. doi: 10.1016/j.athoracsur.2013.03.099. Epub 2013 Jun 21.


Mathematically engineered stromal cell-derived factor-1α stem cell cytokine analog enhances mechanical properties of infarcted myocardium.

MacArthur JW Jr, Trubelja A, Shudo Y, Hsiao P, Fairman AS, Yang E, Hiesinger W, Sarver JJ, Atluri P, Woo YJ.

J Thorac Cardiovasc Surg. 2013 Jan;145(1):278-84. doi: 10.1016/j.jtcvs.2012.09.080.


Re-engineered stromal cell-derived factor-1α and the future of translatable angiogenic polypeptide design.

Hiesinger W, Goldstone AB, Woo YJ.

Trends Cardiovasc Med. 2012 Aug;22(6):139-44. doi: 10.1016/j.tcm.2012.07.010. Epub 2012 Aug 16. Review.


Rapid onset of fulminant myocarditis portends a favourable prognosis and the ability to bridge mechanical circulatory support to recovery.

Atluri P, Ullery BW, MacArthur JW, Goldstone AB, Fairman AS, Hiesinger W, Acker MA, Woo YJ.

Eur J Cardiothorac Surg. 2013 Feb;43(2):379-82. doi: 10.1093/ejcts/ezs242. Epub 2012 May 7.


Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor 1α angiogenic therapy for acute myocardial infarction in a murine model.

Hiesinger W, Brukman MJ, McCormick RC, Fitzpatrick JR 3rd, Frederick JR, Yang EC, Muenzer JR, Marotta NA, Berry MF, Atluri P, Woo YJ.

J Thorac Cardiovasc Surg. 2012 Apr;143(4):962-6. doi: 10.1016/j.jtcvs.2011.12.028. Epub 2012 Jan 20.


Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog.

Hiesinger W, Perez-Aguilar JM, Atluri P, Marotta NA, Frederick JR, Fitzpatrick JR 3rd, McCormick RC, Muenzer JR, Yang EC, Levit RD, Yuan LJ, Macarthur JW, Saven JG, Woo YJ.

Circulation. 2011 Sep 13;124(11 Suppl):S18-26. doi: 10.1161/CIRCULATIONAHA.110.009431.


Oxygen-dependent quenching of phosphorescence used to characterize improved myocardial oxygenation resulting from vasculogenic cytokine therapy.

Hiesinger W, Vinogradov SA, Atluri P, Fitzpatrick JR 3rd, Frederick JR, Levit RD, McCormick RC, Muenzer JR, Yang EC, Marotta NA, MacArthur JW, Wilson DF, Woo YJ.

J Appl Physiol (1985). 2011 May;110(5):1460-5. doi: 10.1152/japplphysiol.01138.2010. Epub 2011 Feb 3.


Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.

Hiesinger W, Frederick JR, Atluri P, McCormick RC, Marotta N, Muenzer JR, Woo YJ.

J Thorac Cardiovasc Surg. 2010 Nov;140(5):1174-80. doi: 10.1016/j.jtcvs.2010.08.012.


Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis.

Frederick JR, Fitzpatrick JR 3rd, McCormick RC, Harris DA, Kim AY, Muenzer JR, Marotta N, Smith MJ, Cohen JE, Hiesinger W, Atluri P, Woo YJ.

Circulation. 2010 Sep 14;122(11 Suppl):S107-17. doi: 10.1161/CIRCULATIONAHA.109.930404.


Acute myocardial rescue with endogenous endothelial progenitor cell therapy.

Atluri P, Panlilio CM, Liao GP, Hiesinger W, Harris DA, McCormick RC, Cohen JE, Jin T, Feng W, Levit RD, Dong N, Woo YJ.

Heart Lung Circ. 2010 Nov;19(11):644-54. doi: 10.1016/j.hlc.2010.06.1056. Epub 2010 Aug 16.


Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device.

Fitzpatrick JR 3rd, Frederick JR, Hiesinger W, Hsu VM, McCormick RC, Kozin ED, Laporte CM, O'Hara ML, Howell E, Dougherty D, Cohen JE, Southerland KW, Howard JL, Paulson EC, Acker MA, Morris RJ, Woo YJ.

J Thorac Cardiovasc Surg. 2009 Apr;137(4):971-7. doi: 10.1016/j.jtcvs.2008.09.021.


Off-pump, minimally invasive and robotic coronary revascularization yield improved outcomes over traditional on-pump CABG.

Atluri P, Kozin ED, Hiesinger W, Woo YJ.

Int J Med Robot. 2009 Mar;5(1):1-12. doi: 10.1002/rcs.230. Review.


Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure.

Atluri P, Hiesinger W, Gorman RC, Pochettino A, Jessup M, Acker MA, Morris RJ, Woo YJ.

J Cardiothorac Surg. 2008 May 7;3:26. doi: 10.1186/1749-8090-3-26.


Transmyocardial revascularization to enhance myocardial vasculogenesis and hemodynamic function.

Atluri P, Panlilio CM, Liao GP, Suarez EE, McCormick RC, Hiesinger W, Cohen JE, Smith MJ, Patel AB, Feng W, Woo YJ.

J Thorac Cardiovasc Surg. 2008 Feb;135(2):283-91, 291.e1; discussion 291. doi: 10.1016/j.jtcvs.2007.09.043. Epub 2008 Jan 11.


Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression.

Atluri P, Morine KJ, Liao GP, Panlilio CM, Berry MF, Hsu VM, Hiesinger W, Cohen JE, Joseph Woo Y.

Cell Mol Biol Lett. 2007;12(1):127-38. Epub 2006 Nov 19.

Supplemental Content

Loading ...
Support Center